162 related articles for article (PubMed ID: 8031515)
1. High mortality among HIV-infected injecting drug users without AIDS diagnosis: implications for HIV infection epidemic modellers?
van Haastrecht HJ; van den Hoek AJ; Coutinho RA
AIDS; 1994 Mar; 8(3):363-6. PubMed ID: 8031515
[TBL] [Abstract][Full Text] [Related]
2. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis.
Hendriks JC; Satten GA; van Ameijden EJ; van Druten HA; Coutinho RA; van Griensven GJ
AIDS; 1998 Aug; 12(12):1537-44. PubMed ID: 9727576
[TBL] [Abstract][Full Text] [Related]
3. Pre-AIDS mortality and its association with HIV disease progression in haemophilic men, injecting drug users and homosexual men.
Prins M; Sabin CA; Lee CA; Devereux H; Coutinho RA
AIDS; 2000 Aug; 14(12):1829-37. PubMed ID: 10985321
[TBL] [Abstract][Full Text] [Related]
4. Estimating the size of the HIV epidemic among injecting drug users in Amsterdam.
van Haastrecht HJ; Bindels PJ; van den Hoek AA; Coutinho RA
Eur J Epidemiol; 1997 Apr; 13(3):261-5. PubMed ID: 9258523
[TBL] [Abstract][Full Text] [Related]
5. Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study.
Prins M; Veugelers PJ
AIDS; 1997 Apr; 11(5):621-31. PubMed ID: 9108944
[TBL] [Abstract][Full Text] [Related]
6. [Estimate of the number of HIV-infected intravenous drug users in Amsterdam].
van Haastrecht HJ; Bindels PJ; van den Hoek JA; Coutinho RA
Ned Tijdschr Geneeskd; 1992 Jun; 136(23):1111-4. PubMed ID: 1603172
[TBL] [Abstract][Full Text] [Related]
7. Longer survival after HIV infection for injecting drug users than for homosexual men: implications for immunology.
Pehrson P; Lindbäck S; Lidman C; Gaines H; Giesecke J
AIDS; 1997 Jul; 11(8):1007-12. PubMed ID: 9223735
[TBL] [Abstract][Full Text] [Related]
8. Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy.
Mocroft A; Gatell J; Reiss P; Ledergerber B; Kirk O; Vella S; Blaxhult A; Phillips AN; Lundgren J;
AIDS; 2004 Nov; 18(17):2333-7. PubMed ID: 15577550
[TBL] [Abstract][Full Text] [Related]
9. Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men.
Spijkerman IJ; Koot M; Prins M; Keet IP; van den Hoek AJ; Miedema F; Coutinho RA
AIDS; 1995 Sep; 9(9):1085-92. PubMed ID: 8527083
[TBL] [Abstract][Full Text] [Related]
10. Increasing morbidity without rise in non-AIDS mortality among HIV-infected intravenous drug users in Amsterdam.
Mientjes GH; van Ameijden EJ; van den Hoek AJ; Coutinho RA
AIDS; 1992 Feb; 6(2):207-12. PubMed ID: 1558718
[TBL] [Abstract][Full Text] [Related]
11. Low serum thiol levels predict shorter times-to-death among HIV-infected injecting drug users.
Marmor M; Alcabes P; Titus S; Frenkel K; Krasinski K; Penn A; Pero RW
AIDS; 1997 Sep; 11(11):1389-93. PubMed ID: 9302450
[TBL] [Abstract][Full Text] [Related]
12. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.
Mientjes GH; van Ameijden EJ; van den Hoek AJ; Goudsmit J; Miedema F; Coutinho RA
AIDS; 1993 Oct; 7(10):1363-70. PubMed ID: 8267910
[TBL] [Abstract][Full Text] [Related]
13. Pre-AIDS mortality in the Edinburgh City Hospital HIV cohort.
Seaman SR; Brettle RP; Gore SM
Stat Med; 1997 Nov; 16(21):2459-74. PubMed ID: 9364654
[TBL] [Abstract][Full Text] [Related]
14. [Mortality in a cohort of intravenous drug users before the introduction of potent HIV therapy].
Muga R; Egea JM; Navío M; Sirera G; Vall M; Tor J
Med Clin (Barc); 1999 May; 112(19):721-5. PubMed ID: 10394568
[TBL] [Abstract][Full Text] [Related]
15. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.
Matser A; Urbanus A; Geskus R; Kretzschmar M; Xiridou M; Buster M; Coutinho R; Prins M
Addiction; 2012 Mar; 107(3):614-23. PubMed ID: 21919987
[TBL] [Abstract][Full Text] [Related]
16. Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model.
Hendriks JC; Craib KJ; Veugelers PJ; van Druten HA; Coutinho RA; Schechter MT; van Griensven GJ
Int J Epidemiol; 2000 Jun; 29(3):565-72. PubMed ID: 10869332
[TBL] [Abstract][Full Text] [Related]
17. Mortality is influenced by locality in a major HIV/AIDS epidemic.
Druyts EF; Rachlis BS; Lima VD; Harvard SS; Zhang W; Brandson EK; Strathdee SA; Montaner JS; Hogg RS
HIV Med; 2009 May; 10(5):274-81. PubMed ID: 19210694
[TBL] [Abstract][Full Text] [Related]
18. Death from suicide and overdose among drug injectors after disclosure of first HIV test result.
van Haastrecht HJ; Mientjes GH; van den Hoek AJ; Coutinho RA
AIDS; 1994 Dec; 8(12):1721-5. PubMed ID: 7888122
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study.
Dorrucci M; Pezzotti P; Phillips AN; Alliegro MB; Rezza G
AIDS; 1997 Mar; 11(4):461-7. PubMed ID: 9084793
[TBL] [Abstract][Full Text] [Related]
20. Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users.
van Haastrecht HJ; van Ameijden EJ; van den Hoek JA; Mientjes GH; Bax JS; Coutinho RA
Am J Epidemiol; 1996 Feb; 143(4):380-91. PubMed ID: 8633622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
